Purdue innovators moving to fast-track COVID-19 diagnostic, therapeutic solutions

otc-covid

Purdue University scientists are working to move solutions to diagnose and treat COVID-19 to the marketplace as soon as possible. (Stock image)

WEST LAFAYETTE, Ind. – As the coronavirus pandemic spreads across the U.S. and the world, Purdue University scientists are working to move solutions to diagnose and treat the virus to the marketplace as soon as possible.

The Purdue Research Foundation Office of Technology Commercialization is working with innovators from across the university to patent and license technologies that focus on the diagnostic and therapeutic aspects of treating COVID-19.

Among the technologies being developed:

* Paper-based and microfluidic, rapid-detection systems that are cheap and portable solutions to diagnose COVID-19 in the field.

* Drugs and vaccine options for treating and preventing coronavirus infections.

* Environmental and surface decontamination technologies to sterilize surfaces, water and air.

“We are expediting the review and processing components of our pipeline to move these inventions from Purdue to a world in need,” said Brooke Beier, vice president of OTC. “We are intensely seeking industry partners to help us accomplish this mission.”

/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.